Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/10/2012 | US20120115235 Enhanced cellulase expression in s. degradans |
05/10/2012 | US20120115234 Down-regulation of gene expression using artificial micrornas |
05/10/2012 | US20120115233 Leafhopper Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
05/10/2012 | US20120115232 Method for inducing degradation of protein in mammalian cell |
05/10/2012 | US20120115231 Novel lysophospholipid acyltransferase |
05/10/2012 | US20120115229 Embryonic stem cells and neural progenitor cells derived therefrom |
05/10/2012 | US20120115228 Oligomeric compounds and compositions for the use in modulation of micrornas |
05/10/2012 | US20120115227 Gene transfer vectors comprising genetic insulator elements and methods to identify genetic insulator elements |
05/10/2012 | US20120115220 Anti-MicroRNA Oligonucleotide Molecules |
05/10/2012 | US20120115219 High affinity binding site of HGFR and methods for identification of antagonists thereof |
05/10/2012 | US20120115208 Modular method for rapid assembly of dna |
05/10/2012 | US20120115207 Enhanced production of papillomavirus-like particles with a modified baculovirus expression system |
05/10/2012 | US20120115205 Botulinum Neurotoxin Serotype B Activatable Botulinum Neurotoxin Serotype Bs |
05/10/2012 | US20120115203 Method for producing 4-hydroxy-l-isoleucine |
05/10/2012 | US20120115202 Photocatalytic hydrogen production in cyanobacteria |
05/10/2012 | US20120115188 Chimeric dna polymerases |
05/10/2012 | US20120115186 Fermentative production of ethanol from glucose, galactose and arabinose employing a recombinant yeast strain |
05/10/2012 | US20120115164 Mammalian cytokines; related reagents |
05/10/2012 | US20120115156 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
05/10/2012 | US20120115151 Method for testing a subject thought to be predisposed to having metastatic cancer using delta133p53beta |
05/10/2012 | US20120115136 Pna diagnostic use |
05/10/2012 | US20120115134 Methods for diagnosis and prognosis of cancer |
05/10/2012 | US20120114799 Polypeptides Having Phytase Activity and Polynucleotides Encoding Same |
05/10/2012 | US20120114759 Peptide/particle delivery systems |
05/10/2012 | US20120114744 Compositions and methods to treat muscular & cardiovascular disorders |
05/10/2012 | US20120114708 Integrin heterodimer and an alpha subunit thereof |
05/10/2012 | US20120114700 Lat adapter molecule for enhanced t-cell signaling and method of use |
05/10/2012 | US20120114698 Salmonella marker vaccine |
05/10/2012 | US20120114693 Nucleic acid mucosal immunization |
05/10/2012 | US20120114691 Vaccine against african horse sickness virus |
05/10/2012 | US20120114688 Vaccines comprising non-specific nucleoside hydrolase and sterol 24-c-methyltransferase (smt) polypeptides for the treatment and diagnosis of leishmaniasis |
05/10/2012 | US20120114684 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/10/2012 | US20120114683 Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences |
05/10/2012 | US20120114680 Dendritic Cell Compositions and Methods |
05/10/2012 | US20120114674 Molecular Antigen Array |
05/10/2012 | US20120114672 Antibodies Specific to Cadherin-17 |
05/10/2012 | US20120114667 TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF |
05/10/2012 | US20120114665 Human antibodies to human rankl |
05/10/2012 | US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family |
05/10/2012 | US20120114659 Antibodies for Guanylyl Cyclase Receptors |
05/10/2012 | US20120114657 Human Monoclonal Antibody Specific for Lipopolysaccharides (LPS) of Serotype IATS 01 of Pseudomonas Aeruginosa |
05/10/2012 | US20120114655 Xylan utilization regulon for efficient bioprocessing of hemicellulose and uses thereof |
05/10/2012 | US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a) |
05/10/2012 | US20120114652 Anti-pai-1 antibodies and methods of use thereof |
05/10/2012 | US20120114650 Single chain antibodies against beta-amyloid peptide |
05/10/2012 | US20120114647 anti-serum album single variable domains |
05/10/2012 | US20120114630 Variants of plasminogen and plasmin |
05/10/2012 | US20120114620 Engineered Dendritic Cells and Uses for the Treatment of Cancer |
05/10/2012 | US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system |
05/10/2012 | US20120114613 Definitive endoderm cell populations |
05/10/2012 | US20120114612 Oncolytic Viruses And Methods For Treating Neoplastic Disorders |
05/10/2012 | US20120114610 Novel endophytic fungi and methods of use |
05/10/2012 | US20120114607 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules |
05/10/2012 | CA2854619A1 Methods for producing virus particles with simplified glycosylation of surface proteins |
05/10/2012 | CA2821299A1 Linking sequence reads using paired code tags |
05/10/2012 | CA2818080A1 Densovirus-derived vector for gene transfer in insects |
05/10/2012 | CA2816959A1 Soybean markers linked to scn resistance |
05/10/2012 | CA2816916A1 High amylose wheat |
05/10/2012 | CA2816803A1 Dual variable domain immunoglobulins and uses thereof |
05/10/2012 | CA2816796A1 Preparation of neutralizing antibody to human herpesvirus 6 glycoprotein q1 and analysis thereof |
05/10/2012 | CA2816702A1 Analysis of fragmented genomic dna in droplets |
05/10/2012 | CA2816584A1 Compositions of a peptide-based system for cell-specific targeting |
05/10/2012 | CA2816575A1 A new variant of antihemophilic factor viii having increased specific activity |
05/10/2012 | CA2816352A1 Dsmz 24726 for second generation bioethanol production |
05/10/2012 | CA2816311A1 Gardnerella vaginalis assay |
05/10/2012 | CA2816236A1 Stress-resistant plants and their production |
05/10/2012 | CA2815927A1 Transgenic plants with improved saccharification yields and methods of generating same |
05/10/2012 | CA2815887A1 Plant expression system |
05/10/2012 | CA2815727A1 Modulation of immune responses by the poxviral k4 protein |
05/10/2012 | CA2815430A1 Compositions and methods for production of fermentable sugars |
05/10/2012 | CA2815426A1 Compositions and methods for the generation of platelets and methods of use thereof |
05/10/2012 | CA2815341A1 Methods for increasing yield and fine chemical production in plants |
05/10/2012 | CA2815266A1 Stable heterodimeric antibody design with mutations in the fc domain |
05/10/2012 | CA2814704A1 Methods and vectors for cell immortalisation |
05/09/2012 | EP2450455A1 Method for determining presence or absence of epithelial cancer-origin cell in biological sample, and molecular marker and kit therefor |
05/09/2012 | EP2450451A1 Method for racemizing optically active -amino acids |
05/09/2012 | EP2450448A1 Methods for plant transformation using spectinomycin selection |
05/09/2012 | EP2450447A1 Manipulation of plant senescence using modified promoters |
05/09/2012 | EP2450446A2 Increasing levels of nicotinic alkaloids |
05/09/2012 | EP2450445A1 Mutant G-protein coupled receptor with increased conformational stability |
05/09/2012 | EP2450442A1 Compositions and methods of using chondroitinase abci mutants |
05/09/2012 | EP2450440A1 Fibrinogenolytic enzyme tabfiblysin of horsefly, tabanus yao, encoding gene and use thereof |
05/09/2012 | EP2450438A1 Cellulase preparation containing endoglucanases derived from two different types of microorganisms |
05/09/2012 | EP2450437A2 Gene defects and mutant ALK kinase in human solid tumors |
05/09/2012 | EP2450435A1 Maltotriocil transferase, process for production thereof, and use thereof |
05/09/2012 | EP2450434A2 Process for the production of arachidonic acid and/or eicosapentaenoic acid |
05/09/2012 | EP2450430A1 Bioassay method for antibody against thyroid-stimulating hormone receptor, measurement kit for the antibody, and novel genetically modified cell for use in the bioassay method or the measurement kit |
05/09/2012 | EP2450381A1 Anti-RHD monoclonal antibodies |
05/09/2012 | EP2450379A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
05/09/2012 | EP2450378A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
05/09/2012 | EP2450377A1 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
05/09/2012 | EP2450376A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
05/09/2012 | EP2450373A2 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
05/09/2012 | EP2450032A2 Microvesicles derived from nucleated, mammalian cells and use thereof |
05/09/2012 | EP2449135A1 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
05/09/2012 | EP2449115A2 Methods and kits for high efficiency engineering of conditional mouse alleles |
05/09/2012 | EP2449114A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors |
05/09/2012 | EP2449113A1 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
05/09/2012 | EP2449112A1 Genetically modified rat models for severe combined immunodeficiency (scid) |
05/09/2012 | EP2449111A2 Expression of transcription regulators that provide heat tolerance |